In the latest ERS Podcast Moderator Giovanni Battista Migliori is joined by Simon Tiberi and Onno Akkerman to discuss the new available options to reduce the treatment duration for drug-susceptible patients to 4 months and for MDR-TB patients to 6 months by discussing the important ongoing trials. The speakers also discuss the ideal organization of a clinical department to ensure adequate infection control and the modern approach to monitor the blood levels of anti-TB drugs. Disclaimer from Simon Tiberi: I am an employee of GSK. The opinions shared in this podcast are my own and not the views of my employer.

Listen on Soundcloud

Listen on Spotify